Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
Jörg Mahlich,1,2 Rosarin Sruamsiri1,3 1Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan; 2Düsseldorf Institute for Competition Economics (DICE), University of Düsseldorf, Düsseldorf, Germany; 3Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice,...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Dove Medical Press
2016-08-01
|
| Rangatū: | Patient Preference and Adherence |
| Ngā marau: | |
| Urunga tuihono: | https://www.dovepress.com/persistence-with-biologic-agents-for-the-treatment-of-rheumatoid-arthr-peer-reviewed-article-PPA |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
